EpiVario
Over 30 years at and as Former Executive VP at Merck Pharmaceuticals.
Current board member at several biotech companies, and has participated in several successful exits, including Okairos (GSK), Ligocyte (Takeda) and Novira (Johnson & Johnson).
This person is not in the org chart
This person is not in any offices
EpiVario
EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders.